During the recent lame-duck session, Congress took a big step toward getting an effective antidote to heroin and other addictive substances within reach of more users by increasing the number of addicted patients that private doctors can treat with the promising drug buprenorphine. It's a welcome development for addicts across the country, but especially in Baltimore where the problem is so acute.
Like methadone, buprenorphine is a synthetic opiate that has helped addicts kick the habit. Unlike methadone, however, buprenorphine does not have to be dispensed through a clinic but can be taken at home because it is less likely to be abused. Its effects last longer so it doesn't have to be taken daily, and it can be discontinued within months, not years.
Yet Congress has taken an overly cautious approach to making the drug more widely available, based on initial worries about abuse. As the comfort level has increased with the drug's proven effectiveness, restrictions have eased on the number of patient-addicts hospitals can treat. And this month, the limits on such patients for individual doctors were allowed to go from 30 to 100.
